Le Lézard
Classified in: Health, Science and technology
Subject: FVT

Is Clinical Supply the Weakest Link in Your Chain? Upcoming Webinar Hosted by Xtalks


In this free webinar, learn about the risks of a poorly managed clinical supply chain, including delayed drug availability, aggressive enrollment targets and potential commercialization delays. Drug shortages can lead to reputation loss, patient burdens and impacts on treatment efficacy and retention. The featured speaker will share proactive strategies such as risk identification, market observation and scenario preparedness. Attendees will learn about leveraging technology for demand planning and collaborating with trusted partners to reduce waste, costs and patient risks.

TORONTO, May 8, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar on clinical supply chain management and how technology can be used for demand planning and forecasting to reduce waste, costs and patient risks.

The industry is shifting towards diverse sourcing strategies, including central and local solutions.

Clinical supply chain faces challenges in navigating complex trial designs, waste reduction, cost control and sustainability. Sponsors prioritize resource mindfulness, CO2 footprint reduction and forecasting. Moreover, evolving regulations complicate drug handling, with patient-centric approaches like decentralized trials and direct-to-patient strategies.

Therefore, embracing new technologies, adapting to hybrid models and meeting sponsors' flexibility demands are crucial. The industry is shifting towards diverse sourcing strategies, including central and local solutions.

In this webinar, the speaker will highlight the risks of a poorly managed clinical supply chain, including delayed drug availability, aggressive enrollment targets and potential commercialization delays. Drug shortages can lead to reputation loss, patient burdens and impacts on treatment efficacy and retention.

They will also discuss proactive strategies such as risk identification, market observation and scenario preparedness, as well as emphasize on leveraging technology for demand planning and collaborating with trusted partners to reduce waste, costs and patient risks.

Register for this webinar today to gain insights into clinical supply chain management and understand how technology can be used for demand planning and supply chain forecasting.

Join Benedict Hirth, Global Lead Manager Supply Chain Optimization, Myonex, for the live webinar on Thursday, May 23, 2024, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Is Clinical Supply the Weakest Link in Your Chain?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com 

SOURCE Xtalks


These press releases may also interest you

at 22:00
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: